Ocuphire Pharma Investor Day Presentation Deck
P
103
Presbyopia Market Segments
Tens of Millions of Likely Early Users → Emmetropes, Hyperopes, and Pseudophakes
~128M Presbyopes in the US
●
NORMAL VISION
Emmetropes
Naturally occurring
clear vision
• No refractive
error/post-LASIK
66 M
HYPEROPIA
Hyperopes
Poor near vision
(starting at age 40)
14 M
PSUEDOPHAKIA
Pseudophakes
• Cataract surgery
for artificial lens
(monofocal,
multifocal IOLS)
9 M
Assume 50% use eye drops*
~44 M Patients
Likely To Be Early Users of Presbyopia Eyedrops
Global Prevalence of Presbyopia, 2018, Fortune Business Insights Reading Glasses Forecast 2016-2027, NEI 2010 data. *GlobalData Market Research 2020
Vitale S. et. Al. JAMA Ophthalmology, 2008, Vision problems, US, Arch. Ophthal, 2014, Vision Monday.
MYOPIA
Myopes
Poor distance
vision
39 M
Ocuphire
PHARMAView entire presentation